IRIS
SALZANO, GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.872
AS - Asia 1.516
NA - Nord America 1.378
SA - Sud America 215
AF - Africa 39
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.312
SG - Singapore 865
IT - Italia 769
RU - Federazione Russa 590
CN - Cina 315
BR - Brasile 187
HK - Hong Kong 135
VN - Vietnam 106
DE - Germania 98
FI - Finlandia 82
IE - Irlanda 75
NL - Olanda 56
UA - Ucraina 46
GB - Regno Unito 42
IN - India 41
CA - Canada 39
SE - Svezia 32
FR - Francia 26
MX - Messico 19
PL - Polonia 14
ID - Indonesia 12
ZA - Sudafrica 10
AT - Austria 8
EC - Ecuador 8
AR - Argentina 7
BD - Bangladesh 7
EG - Egitto 7
ES - Italia 7
TR - Turchia 7
JP - Giappone 6
CL - Cile 5
CI - Costa d'Avorio 4
KR - Corea 4
LT - Lituania 4
AU - Australia 3
BE - Belgio 3
CH - Svizzera 3
DZ - Algeria 3
IQ - Iraq 3
MA - Marocco 3
PY - Paraguay 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
KE - Kenya 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CO - Colombia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
ME - Montenegro 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
TZ - Tanzania 1
UG - Uganda 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.025
Salva come PNG Salva come JPEG
Città #
Singapore 396
Hong Kong 135
Moscow 133
Chandler 131
Ashburn 112
Santa Clara 106
Beijing 103
Millbury 73
Princeton 59
Nanjing 55
Naples 51
Los Angeles 42
Ho Chi Minh City 39
Dallas 35
Boston 33
Milan 32
Amsterdam 29
Ottawa 28
Rome 28
Napoli 26
Bologna 24
São Paulo 24
Buffalo 22
Munich 22
Dong Ket 20
Pune 20
Redondo Beach 20
New York 19
The Dalles 19
Hanoi 18
Hebei 17
Nanchang 16
Wilmington 16
Turku 15
Brooklyn 14
Falls Church 14
Florence 14
London 14
Preganziol 13
Des Moines 12
Dublin 11
Warsaw 11
Denver 10
Jacksonville 10
Jiaxing 10
Shenyang 10
Salerno 9
San Francisco 9
Atlanta 8
Caserta 8
Council Bluffs 8
Ercolano 8
Mexico City 8
Mumbai 8
Norwalk 8
Phoenix 8
Cerro Maggiore 7
Helsinki 7
Jakarta 7
Montreal 7
Palermo 7
Stockholm 7
Curitiba 6
Da Nang 6
Padova 6
Tianjin 6
Tokyo 6
Alexandria 5
Ann Arbor 5
Biên Hòa 5
Caxias do Sul 5
Chennai 5
Chicago 5
Orem 5
Poplar 5
Saratov 5
Sassari 5
Seattle 5
Frankfurt am Main 4
Hefei 4
Houston 4
Johannesburg 4
Manchester 4
Perugia 4
Recife 4
Rio de Janeiro 4
Serra 4
Valparaiso 4
Washington 4
Augusta 3
Bacoli 3
Boardman 3
Cagliari 3
Campobasso 3
Canegrate 3
Cattolica 3
Changsha 3
Charlotte 3
Guarulhos 3
Hortolândia 3
Totale 2.347
Salva come PNG Salva come JPEG
Nome #
Microsfere gastroresistenti per la somministrazione orale di bromelaina. 422
Microsfere di PLGA per il rilascio controllato di siRNA anti-TNF-alpha nel trattamento dell’artrite reumatoide. 222
Aggregati supramolecolari, formulati con monomeri anfifilici funzionalizzati con agenti chelanti e con peptidi e loro impiego per la somministrazione selettiva di farmaci e⁄o mezzi di contrasto 134
Liposomi stealth contenenti acido zoledronico per il trattamento del dolore neuropatico 120
Self-assembly lipid-based nanoparticles containing zoledronic acid: a new strategy for the treatment of cancer 110
Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori. 109
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer 106
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid 105
Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012 103
Nanoparticelle auto-assemblanti per la veicolazione di acido zoledronico nel trattamento di tumori nell’uomo. 101
Can stealth liposomes convert a bisphophonate in a anticancer agent? 98
Nanoparticelle auto-assemblanti contenenti acido zoledronico: una nuova strategia per il trattamento del cancro. 98
NEW CXCR4 INHIBITORS COUPLED WITH LIPOSOMES INHIBIT LUNG METASTASES DEVELOPMENT 96
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis 95
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells 94
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors 94
Liposomi stealth contenenti bifosfonati: una nuova strategia contro il cancro. 91
Transferrin-targeted nanoparticles containing zoledronic acid as a potential tool to inhibit glioblastoma growth 87
Bisphosphonates and cancer: what opportunities from nanotechnology? 86
uso dell'acido zoledronico per la preparazione di formulazioni farmaceutiche per il trattamento del cancro della prostata e del mieloma multiplo. 84
Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: Impact of access to genetic testing 83
Nanoparticelle auto-assemblanti per la veicolazione di acido zoledronico nel trattamento di tumori nell’uomo. 82
Acido zoledronico incapsulato nei liposomi: una nuova opportunità contro il cancro 81
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 81
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells 80
Bombesin labelled liposome as target -selective delivery system for doxorubicin 80
Nanotecnologie per l’impiego di bisfosfonati come farmaci antitumorali 79
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 78
PLGA MICROSPHERES FOR LONG TERM DELIVERY OF siRNA AGAINST TNFalfa IN THE TREATMENT OF RHEUMATOID ARTHRITIS. 77
NANOPARTICELLE AUTOASSEMBLANTI PER L???IMPIEGO DI BISFOSFONATI NEL TRATTAMENTO DEL GLIOBLASTOMA 76
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 75
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer 74
PLGA microspheres for the delivery of siRNA against TNF-alpha in the treatment of rheumatoid arthritis 71
SELF-ASSEMBLING NANOPARTICLES ENCAPSULATING ZOLEDRONIC ACID FOR THE TREATMENT OF BRAIN TUMORS 69
Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here 68
Scuola dottorale per la formazione avanzata in discipline tecnologico farmaceutiche 67
Novel stealth self-assembled nanoparticles for the delivery of zoledronic acid in the treatment of solid tumors. 67
Novel Self assembled nanoparticles for Tumor targeted delivery of Zoledronic acid. 66
New self-assembling nanoparticles for bisphosphonate delivery in cancer. 65
New CXCR4 inhibitors coupled with liposomes inhibit lung metastases development. 65
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. 63
PLGA microspheres encapsulating siRNA 63
Liposomes containing zoledronic acid: a new opportunity against cancer. 62
Stealth liposomes containing zoledronic acid for the treatment of neuropathic pain. 62
Liposomes encapsulating zoledronic acid: a new opportunity against cancer. 61
Self-assembling nanoparticles containing zoledronic acid: a new challenge for the treatment of brain tumors 59
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study 58
Stealth liposomes and new self-assembly nanoparticles for the delivery of zoledronic acid: a comparative study. 57
New self-assembling nanoparticles for bisphosphonate delivery in cancer. 57
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts. 56
Polymeric Micelles Co-Loaded with Survivin siRNA and Paclitaxel: A Strategy to Overcome the Multidrug Resistance in Tumor 56
Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer. 55
Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood-Brain-Barrier. 53
Nanoparticelle autoassembanti per l???impiego di bisfosfonati nel trattamento di tumori. 50
Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers 50
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes 49
Nanotechnologies for the delivery of zoledronic acid in tumors. 49
Nanotechnologies: a strategy to overcome blood-brain barrier 44
PLGA microspheres encapsulating siRNA anti-TNFalpha: Efficient RNAi-mediated treatment of arthritic joints. 41
NANOTECHNOLOGIES TO USE ZOLEDRONIC ACID AS A POTENT ANTITUMORAL AGENT 41
null 12
null 10
null 10
null 8
null 5
Totale 5.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 24 6 6 13 10 11 30
2021/2022382 14 2 11 9 8 21 6 17 74 4 65 151
2022/2023403 69 15 19 29 61 42 14 30 52 37 25 10
2023/2024433 22 36 82 25 27 61 17 37 6 20 62 38
2024/20251.568 93 153 19 28 117 44 171 78 110 137 451 167
2025/20261.470 275 171 226 260 473 65 0 0 0 0 0 0
Totale 5.070